Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1
Clinical trial NCT02706886 · COMPLETED
Trial details
- NCT number
- NCT02706886
- Sponsor
- Alnylam Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-08
- Primary completion
- 2019-01-23
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.